Is SIGA Technologies, Inc. FDA approved?

SIGA Technologies, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does SIGA Technologies, Inc. make?

2 products are listed under SIGA Technologies, Inc. in the openFDA NDC Directory, most often as capsule; injection, solution, concentrate. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

SIGA Technologies, Inc.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 2
Live patents: 10
Countries: 0

Catalogue

Drug listings by form and route

2 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.

Dosage form	NDCs
capsule	1
injection, solution, concentrate	1

Route	NDCs
intravenous	1
oral	1

Labeller name on the listing	NDCs
siga technologies, inc.	2

Exclusivity

Patents and exclusivities

Patent	Product	Covers	Expiry
8039504	TPOXXtecovirimat	product	Jul 2027
12433868	TPOXXtecovirimat	product	Mar 2031
9339466	TPOXXtecovirimat	substance, product	Mar 2031
10576165	TPOXXtecovirimat	product	Aug 2031
9233097	TPOXXtecovirimat	product	Aug 2031
9907859	TPOXXtecovirimat	use	Aug 2031
7737168	TPOXXtecovirimat	use	Sept 2031
11890270	TPOXXtecovirimat	use	Aug 2032

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
TPOXX	tecovirimat monohydrate	injection, solution, concentrate, intravenous	50072-010NDA
TPOXX	tecovirimat monohydrate	capsule, oral	50072-200NDA

Enquiry

Common questions

Is SIGA Technologies, Inc. FDA approved?: SIGA Technologies, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does SIGA Technologies, Inc. make?: 2 products are listed under SIGA Technologies, Inc. in the openFDA NDC Directory, most often as capsule; injection, solution, concentrate. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.